Epsilogen Ltd logo
VerifiedBiotechnology· Founded 2016

Epsilogen Ltd

Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life. The company's lead programme targets the folate receptor alpha (FR alpha) and an anti-FR alpha IgE antibody is currently in a phase I trial to treat ovarian cancer. This is the world's first IgE therapeutic to enter the clinic.

7-day free trial · no credit card

HeadquartersUnited KingdomEmployees34(11 to 50)Founded year2016Websiteepsilogen.comLinkedIn profileLinkedIn

Verified contacts

23

available on Kipplo

LinkedIn employees

34

11 to 50 range

Open roles

no listings

Distinct roles

14

indexed titles

Tech stack

0

tools in use

Monthly traffic

26

organic / mo

Sign up free to see all 23 verified contacts at Epsilogen Ltd

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

23 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Epsilogen Ltd

14 distinct titles indexed · top 10 shown.

  • 4research scientist
  • 4senior scientist
  • 2ea office manager
  • 2principal scientist
  • 2project manager
  • 1board observer
  • 1chief financial officer
  • 1chief translational science officer
  • 1laboratory manager
  • 1phage display scientist
  • +4more titles

Sign up to unlock all 23 contacts at Epsilogen Ltd

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 23 verified contacts at Epsilogen Ltd

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Epsilogen Ltd | Kipplo Discover